Gara Jalqabaatti › Neoplasmsiin Akka Gosa Histologic
Qorannoo klinikaalii Neoplasmsiin Akka Gosa Histologic Ameerikaa Keessatti hirmaatuu
Qorannoo 12 Neoplasmsiin Akka Gosa Histologic f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 5
- Atlanta, GAQorannoo 5
- Chicago, ILQorannoo 4
- Houston, TXQorannoo 4
- Los Angeles, CAQorannoo 4
- St. Louis, MOQorannoo 3
- Dallas, TXQorannoo 3
- Clifton, NJQorannoo 3
- Tampa, FLQorannoo 3
- San Francisco, CAQorannoo 3
- Baldwin Park, CAQorannoo 3
- New York City, NYQorannoo 3
- Nashville, TNQorannoo 3
Naannoon
- CaliforniaQorannoo 7
- FloridaQorannoo 6
- GeorgiaQorannoo 6
- IllinoisQorannoo 4
- MassachusettsQorannoo 5
- MichiganQorannoo 4
- MissouriQorannoo 4
- New JerseyQorannoo 5
- New YorkQorannoo 3
- OhioQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05874921Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07416188HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07075185Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT04198766Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06463665A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT05297734A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Hag-2024 · NCT06271252Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.